Table 1.
Compound | IC50 for | Reference | |
---|---|---|---|
INa,late | INa,early | ||
Lidocaine | 29 µM | 367 µM | Antzelevitch et al., 2014 |
Ranolazine | 17 µM | 1329 µM | Belardinelli et al., 2013 |
6 µM | 294 µM | Undrovinas et al., 2006 | |
GS-458967 | 333 nM | <15 % block at 333 nM | Koltun et al., 2016a |
130 nM | 7.5 % reduction at 10 µM | Belardinelli et al., 2013 | |
GS-462808 | 1.9 µM | 10 % reduction at 10 µM | Koltun et al., 2016b |
GS-6615 | 0.62 µM | 51 µM | Zablocki et al., 2016 |
F15845 | 3.25 µM | 23 % reduction at 10 µM | Vacher et al., 2009 |
Where the IC50 value is missing, inhibition percentage at a given concentration was used instead.